Volume 74, Issue 5, Pages 571-576 (September 2008) Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease Linda F. Fried Kidney International Volume 74, Issue 5, Pages 571-576 (September 2008) DOI: 10.1038/ki.2008.231 Copyright © 2008 International Society of Nephrology Terms and Conditions
Figure 1 Mevalonic acid pathway and implications for kidney disease. ECM=extracellular matrix. Data from Liao,37,38 Kim et al.,39 Rikitake and Liao,40 Vecchione et al.,41 Gojo et al.,42 Toblli et al.,43 Xu et al.,44 and McTaggart.45 Kidney International 2008 74, 571-576DOI: (10.1038/ki.2008.231) Copyright © 2008 International Society of Nephrology Terms and Conditions